Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Medicilon was Awarded the Excellent Academician and Expert Workstation of Shanghai and Pudong New Area

2021-01-13
|
Page View:

Recently, Shanghai Medicilon was awarded the title of “Excellent Expert Workstation” by the Shanghai Academician and Expert Workstation Guidance Office and the title of “2020 Pudong New Area Excellent Academician and Expert Workstation” by the Pudong Science and Technology Association.

Excellent Academician and Expert Workstation

Medicilon was awarded the title of “Excellent Expert Workstation” by the Shanghai Academician Expert Workstation Guidance Office Medicilon was awarded the title of “2020 Pudong New Area Excellent Academician and Expert Workstation” by the Pudong Science and Technology Association Shanghai Medicilon builds and improves the R&D platform with the core concept of “innovation-driven, quality first” to ensure that high-quality scientific research resources are used to assist customers and many scientific researchers in new drug research and development projects.

Excellent Academician and Expert Workstation-Pudong

For Medicilon, the double evaluation is both affirmation and encouragement. Medicilon will continue to work hard, not forget its original intention, continue to lean platform resources, improve service quality, and provide support and assistance to more new drug research and development workers. Watch the birth of a new drug!

About Medicilon

Medicilon (stock code: 688202) was established in 2004 and is headquartered in Shanghai. It is committed to providing a full range of preclinical new drug research services for global pharmaceutical companies, research institutions and scientific researchers. Medicilon’s one-stop integrated service helps customers accelerate the development of new drugs with strong project management and more efficient and cost-effective R&D services. The services cover the entire process of preclinical new drug research in medicine, including drug discovery, pharmaceutical research and clinical trials. Pre-research. Medicilon grows together with high-quality customers at home and abroad, and provides new drug research and development services to more than 700 customers around the world. Medicilon will continue to base itself on a global perspective, gather Chinese innovation, and contribute to human health!

contact us

Email: marketing@medicilon.com

Phone: +86 (21) 5859-1500

Return
Relevant newsRelevant news